Color becomes the first and only Virtual Cancer Clinic to achieve ASCO certification.
Cancer care that delivers on cost, outcomes, and credibility
Color partners with consultants to bring a complete end to end clinical cancer care program to their clients that delivers results across experiences, outcomes, and costs.
Don’t let them face the complexities of cancer****alone
Cancer is one of the largest and least controlled drivers of employer healthcare spend, and you are being asked to solve it. To do so, you need to think beyond just treatment costs and dig into the avoidable drivers like low screening rates, lack of follow-up, delayed diagnoses, and uncoordinated care during treatment and survivorship. When there is no single accessible partner taking responsibility, the cracks in traditional solutions show up as higher costs and worse outcomes.
With Color, you can help them change course, improve outcomes, and lower spend.
"We are so glad to have invested in our employees' lives with Color and are seeing great impact already on the dialogue around cancer care and prevention in our workforce, as well as on screening rates."
Noora Garnett
former VP of Global Benefits, Hasbro
“I saw that this program would impact our entire population... It speaks to everyone, and everyone can partake in it.”
Janet Acosta
HR Benefits Manager, Hot Topic
"Our employees are incredibly engaged with Color, and the feedback has been overwhelmingly positive."
Chris Miller
VP, Total Rewards, Michael Baker International
"A member was diagnosed just 18 days after that initial screening, which can typically take up to six months."
Kristina Ewing
Director of Health and Wellbeing, Andersen Construction
“I absolutely feel Color should be a core part of healthcare benefits.”
Maria Scheeler
Executive Director, Teamsters Health & Welfare Fund of Philadelphia and Vicinity
“Color offers personalized screening for early detection, quick access to world-class treatments, and ongoing survivorship support long after they ring that bell.”
Kayla Johnson
Executive Director, HR Operations Supervisor, Marsh McLennon Agency
010203040506
Color helps you deliver the results clients need
65% faster diagnosis
75% increase in screening adherence
73% of costly care gaps
$22,351 saved per patient
$5,831 saved per survivor
2.8:1 ROI in Year 1
A true clinical partner meets your clients’ needs
For the complexities of cancer care, Color delivers an oncologist-led program that engages employees and delivers across detection, treatment, and survivorship and return to work. Color takes ownership where most traditional solutions fall short.
Explore the Virtual Cancer Clinic
Frequently asked questions
How does Color support consultants?
Color gives consultants a clinically credible, outcomes-driven solution that addresses cancer across the full journey for their benefit clients. This allows consultants to move beyond point solutions and offer clients a cohesive strategy grounded in measurable impact with proven outcomes.
How is Color different from navigation or point solutions?
Unlike navigation programs, Color provides oncologist-led direct clinical care. Our clinicians actively manage risk, diagnosis, treatment, and survivorship rather than simply routing employees back into fragmented care systems.
Where does Color fit in a benefits portfolio?
Color functions as a dedicated cancer care layer that integrates with medical plans, COEs, and other benefits. It simplifies cancer strategy by consolidating what is often spread across multiple vendors.
What outcomes does Color deliver?
Consultants can reference improvements in screening adherence, faster diagnoses, closure of high-cost care gaps, reduced avoidable utilization, and strong financial returns driven by earlier intervention and clinical oversight.
How does Color simplify cancer benefit discussions?
Color simplifies cancer benefit discussions by replacing fragmented point solutions with a single oncologist-led clinical cancer care program. This makes it easier for consultants to explain value, differentiation, and ROI across early detection, treatment, and survivorship.